Delivery Order SPE2DR25D3301-SPE2DR26F19DN
- Not listed
- The Defense Logistics Agency awarded a $4,852.12 delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for HUMIRA (adalimumab) 40 mg/0.4 mL prefilled pens. This competitively awarded, firm fixed-price contract is a non-set-aside delivery order with an ultimate completion date of November 4, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a child order under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a $12,559.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of HUMIRA (Adalimumab) 40 mg/0.4 mL prefilled pens. This non-competitive delivery order was issued on December 1, 2025, with an ultimate completion date of December 2, 2025, and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle...
- The Defense Logistics Agency awarded a $7,163.82 delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of HUMIRA (adalimumab) 40 mg/0.4 mL prefilled pens. This competitively awarded, non-set-aside contract is classified as a firm fixed-price delivery order with an ultimate completion date of November 18, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $13,075.97 delivery order to AmerisourceBergen Drug Corp for HUMIRA (Adalimumab) prefilled pens, 40 mg/0.4 mL dosage. This contract is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters location. This delivery order is issued under...
- The Defense Logistics Agency awarded a $6,405.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of HUMIRA (adalimumab) prefilled pens at 40 mg/0.4 ml dosage. This is a non-set-aside, competitively awarded contract with a completion date of September 29, 2025, and performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,591.96 to AmerisourceBergen Drug Corp for Humira (adalimumab) prefilled pens at 40 mg/0.4 mL on November 13, 2025, with completion expected by November 14, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single pharmaceutical procurement fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,387.94 to AmerisourceBergen Drug Corp for HUMIRA (adalimumab) prefilled pens, 40 mg/0.4 mL formulation. This non-competitive, firm fixed-price delivery order was issued on December 5, 2025, with an ultimate completion date of December 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a $1,591.96 delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Humira (adalimumab) prefilled pens at 40 mg/0.4 mL. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of November 6, 2025. The award represents a single transaction under a broader pharmaceutical supply relationship supporting federal...
- The Defense Logistics Agency awarded a $17,091.36 delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of HUMIRA (adalimumab) prefilled pens at 40 mg/0.4 mL. This is a competitively awarded, firm fixed price contract with no set-aside designation and an ultimate completion date of October 29, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary pharmaceutical distribution...
- The Defense Logistics Agency awarded a delivery order valued at $4,132.38 to AmerisourceBergen Drug Corp for HUMIRA (Adalimumab) prefilled pens at 40 mg/0.4 mL. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of December 8, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills this order under its...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F19DNDelivery Order
The Defense Logistics Agency awarded a $5,024.93 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of HUMIRA (adalimumab) prefilled pens at 40 mg/0.4 mL dosage strength. This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion master contract vehicle extending through December 2026 that serves as the primary pharmaceutical supply mechanism for military and federal healthcare systems worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor in the federal medical procurement ecosystem, regularly fulfilling competitively awarded delivery orders for a broad range of medications and medical supplies supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare customers. The SPE2DX contract under which this order was placed encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. This specific delivery order represents routine pharmaceutical replenishment for HUMIRA, an immunosuppressant widely used in military and federal healthcare systems for treating rheumatoid arthritis and other autoimmune conditions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 12/7/25 |